Observational studyMovement disorders clinical practice2025

Clinical Impact of Switching from Subcutaneous Apomorphine to Foslevodopa/Foscarbidopa in Advanced Parkinson's Disease: A Real-World Observational Study (FOSAPO).

Clément Desjardins et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.